Evidence map›Paper›PMID 27102705›Full record

ArticleThe Enzymes

Effects of Tea Catechins on Cancer Signaling Pathways.

Chung S Yang, Hong Wang, Jayson X Chen, Jinsong Zhang

Abstract read
In one paragraph

Article in The Enzymes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nutrients · 2022
    Article
  5. Anticarcinogenic potentials of tea catechins.Frontiers in nutrition · 2022
    Review
  6. Article
  7. Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.Progress in the chemistry of organic natural products · 2021
    Article
  8. Review
  9. Apoptotic-Induced Effects ofInternational journal of molecular sciences · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Cancer Preventive Activities of Tea Catechins.Molecules (Basel, Switzerland) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chung S YangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA; International Joint Research Laboratory of Tea Chemistry and Health Effects, Anhui Agricultural University, Hefei, PR China. Electronic address: csyang@pharmacy.rutgers.edu.
Hong WangDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Jayson X ChenDepartment of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Jinsong ZhangInternational Joint Research Laboratory of Tea Chemistry and Health Effects, Anhui Agricultural University, Hefei, PR China.
Anhui Agricultural University · CNRutgers, The State University of New Jersey · US

Funding

TRAINING IN EVIRONMENTAL TOXICOLOGYT32ES007148 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Lauren M Aleksunes · 1987 to 2026
$11.4M
Prevention of Colon Cancer by Epigallocatechin Gallate and AtorvastatinR01CA120915 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2007 to 2011
$1.8M
Mechanistic Studies on Lung Cancer Prevention by Tea PolyphenolsR01CA122474 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2008 to 2012
$1.6M
Inhibition of Lung Carcinogenesis by Tea Polyphenols and AtorvastatinR01CA133021 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI YANG, CHUNG S. · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA120915NCI NIH HHS R01 CA122474NCI NIH HHS R01 CA133021NIEHS NIH HHS T32 ES007148
6 · The paper itself

Abstract

The inhibitory activities of tea catechins against carcinogenesis and cancer cell growth have been demonstrated in a large number of laboratory studies. Many mechanisms for modulating cancer signaling and metabolic pathways have been proposed based on numerous studies in cell lines with (-)-epigallocatechin-3-gallate, the most abundant and active tea catechin. Nevertheless, the molecular basis for the proposed mechanisms and whether these mechanisms indeed contribute to the anticancer activities in vivo are not clearly known. This chapter reviews the basic redox properties of tea catechins, their binding to key enzymes and signal transduction proteins, and other mechanisms that lead to suppression of cell proliferation, increased apoptosis, and inhibition of angiogenesis. More weight is put on studies in vivo over experiments in vitro. It also discusses key issues involved in extrapolating results from cell line studies to mechanistic insights in vivo.

Indexed as

Animal modelsCancer signalingCell linesEGCGTea catechins

Identifiers

PMID27102705
PMCPMC5659712
OpenAlexW2484888377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.